Conmed (NYSE:CNMD) reported its Q4 earnings results on Wednesday, January 31, 2024 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Conmed missed estimated earnings by 4.5%, reporting an EPS of $1.06 versus an estimate of $1.11.
Revenue was up $76.18 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 2.95% increase in the share price the next day.
Here’s a look at Conmed’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.83 | 0.79 | 0.60 | 0.90 |
| EPS Actual | 0.90 | 0.83 | 0.66 | 0.42 |
| Revenue Estimate | 300.91M | 306.09M | 266.67M | 302.51M |
| Revenue Actual | 304.58M | 317.65M | 295.47M | 250.87M |
To track all earnings releases for Conmed visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
